Urticaria and angioedema from bench to bedside

Urticaria and angioedema from bench to bedside

Dupilumab Efficacy in Patients With Chronic Spontaneous Urticaria by IgE Level and IgE Over Time: LIBERTY-CSU CUPID Study A

Barzolvolimab Demonstrates Clinical Activity in a Multiple Ascending Dose Trial in Chronic Spontaneous Urticaria

Real-world patient burden of hereditary angioedema (HAE) and impact on quality of life (QoL) in regions with limited HAE management options and highest unmet needs

Clinical outcomes and quality of life in patients with HAE receiving lanadelumab long-term prophylaxis: Interim analysis of 3-year real-world data